5-HT Receptor
5-HT receptor (5-hydroxytryptamine receptors) is a group of GPCRs (G protein-coupled receptors) and LGICs (ligand-gated ion channels) found in the central and peripheral nervous systems.
Products for 5-HT Receptor
- Cat.No. Product Name Information
- GC14392 SB 242084 5-HT2C receptor antagonist
- GC15138 SB 243213 dihydrochloride SB 243213 dihydrochloride is an orally active, selective and high-affinity 5-HT2C receptor antagonist with a pKi of 9.37 and a pKb of 9.8 for human 5-HT2C receptor.
- GC38173 SB 243213 hydrochloride
- GC12383 SB 258585 hydrochloride 5-HT6 receptor antagonist
- GC37596 SB 258719 SB 258719 is a selective 5-HT7 receptor antagonist with high affinity (pKi=7.5) for the receptor.
- GC12798 SB 258719 hydrochloride Selective 5-HT7 receptor antagonist
- GC37597 SB 271046 Hydrochloride SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively.
- GC15660 SB 399885 hydrochloride 5-HT6 antagonist
- GC12524 SB 699551 5-ht5a receptor antagonist
- GC44875 SB-242084 (hydrochloride) SB 242084 hydrochloride is a 5-HT2C receptor antagonist(pKi=9.0) that displays 158- and 100-fold selectivity over 5-HT2A and 5-HT2B receptors respectively.
- GC37599 SB-269970 SB-269970 is a potent, selective and brain-penetrant 5-HT7 receptor antagonist with a pKi of 8.3.
- GC31025 SB-616234A SB-616234A is a selective and orally bioavailable 5-HT1B receptor antagonist, with anxiolytic and antidepressant activity.
- GC38492 SB228357
- GC10769 SB269970 HCl SB269970 HCl is a potent, selective and brain-penetrant 5-HT7 receptor antagonist with a pKi of 8.3.
- GC14550 SB271046 5-HT6 receptor antagonist, orally active
- GC12091 SB742457 SB742457 (SB742457) is a highly selective 5-HT6 receptor antagonist with pKi of 9.63; exhibits >100-fold selectivity over other receptors.
- GC17219 SDZ 205-557 hydrochloride 5-HT3/5-HT4 receptor antagonist
- GC12735 SDZ SER 082 fumarate 5-HT2B/2C receptor antagonist
- GC14843 Serotonin HCl Endogenous 5-HT receptor agonist
-
GC69879
Serotonin-d4
Serotonin-d4 is a deuterated derivative of serotonin. Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also an inhibitor of catechol-O-methyltransferase (COMT), with a Ki value of 44 μM.
- GC30787 Sertindole (Lu 23-174) Sertindole (Lu 23-174) (Lu 23-174) is an orally active 5-HT2A, 5-HT2C, dopamine D2, and αl-adrenergic receptors antagonist.
- GC10991 SGS 518 oxalate 5-HT6 antagonist
- GC11416 Spiperone hydrochloride 5-HT2A serotonin and selective D2-like dopamine receptor antagonist
-
GC15630
SR 57227 hydrochloride
A 5-HT3 receptor agonist
- GC16910 ST 1936 oxalate ST 1936 oxalate is a selective, nanomolar affinity 5-HT6 receptor agonist with Ki values of 13 nM, 168 nM and 245 nM for human 5-HT6, 5-HT7 and 5-HT2B receptors, respectively.
- GC34033 Sulamserod (RS-100302) Sulamserod (RS-100302) is a 5-HT4 receptor antagonist, with antiarrhythmic activities.
- GC31044 T 82 T 82 is a potent 5-HT3 antagonist and acetylcholinesterase (AChE) inhibitor, used for treatment of Alzheimer's Disease.
- GC10945 Tandospirone Anxiolytic and antidepressant reagent
- GC37734 Tandospirone citrate Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).
- GC11490 TCB-2 5-HT2A receptor agonist
- GC30273 Tedatioxetine hydrobromide (Lu AA 24530 hydrobromide) Tedatioxetine (Lu AA24530) hydrobromide acts as a serotonin and norepinephrine (NE)-preferring triple reuptake inhibitor (TRI) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist.
- GC17826 Tegaserod maleate Partial agonist of 5-HT4
- GC30826 Temanogrel (APD791) Temanogrel (APD791) is a highly selective 5-HT2A receptor antagonist with a Ki of 4.9 nM.
- GC32637 Tertatolol ((±)-Tertatolol) Tertatolol ((±)-Tertatolol) is a potent antagonist of beta-adrenoceptor and 5-HT receptor, with unique renal vasodilatatory effects.
- GC19354 TG6-10-1 TG6-10-1 is an EP2 antagonist, shows low-nanomolar antagonist activity against only EP2, >300-fold selectivity over human EP3, EP4, and IP receptors, 100-fold selectivity over EP1 receptors.
- GC11977 Thioridazine HCl Thioridazine HCl, an orally active antagonist of the dopamine receptor D2 family proteins, exhibits potent anti-psychotic and anti-anxiety activities.
- GC10121 Tianeptine sodium Tianeptine sodium is a selective facilitator of 5-HT uptake.
- GC26002 Trazodone Trazodone (AF-1161) is a 5-HT 2A/2C receptor antagonist that is used as an antidepressant for treating major depressive disorder and anxiety disorders.
- GC14927 Trazodone HCl Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.
- GC17488 Trimipramine (maleate) potent antagonist of histamine H1 receptor
- GC16284 Tropisetron 5-HT3 receptor antagonist
- GC15223 Tropisetron Hydrochloride 5-HT3 receptor antagonist
- GC65265 UNC9994 hydrochloride UNC9994 hydrochloride is a functionally selective, β-arrestin–biased dopamine D2 receptor (D2R) agonist that selectively activates β-arrestin recruitment and signaling.
- GC37861 Urapidil Urapidil is an α1 adrenoreceptor antagonist and a 5-HT1A receptor agonist.
- GC15829 Urapidil HCl Urapidil HCl is an orally active α1-adrenoceptor antagonist and 5-HT1A receptor agonist with a pIC50 of 6.13 and 4.38 against α1- and α2-adrenoceptor, respectively.
- GC64080 Usmarapride Usmarapride (SUVN-D4010) is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM).
- GC64660 Usmarapride free base Usmarapride (SUVN-D4010) free base is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM).
- GC30964 Vabicaserin hydrochloride (SCA 136) Vabicaserin hydrochloride (SCA 136) is a 5-hydroxytryptamine 2C (5-HT2C) receptor-selective agonist with an EC50 of 8 nM.
- GC10911 Venlafaxine hydrochloride Dual serotonin/noradrenalin re-uptake inhibitor
- GC37906 Vilazodone D8 Vilazodone D8 is the a deuterium labeled vilazodone, which is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist.
- GC14437 Vortioxetine (Lu AA21004) HBr Vortioxetine (Lu AA21004) HBr is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
- GC13501 VUF 10166 5-HT3 receptor antagonist
- GC11980 WAY 161503 hydrochloride 5-HT2C receptor agonist
- GC33344 WAY 163909 WAY 163909 is a potent and selective 5-HT(2C) receptor agonist with a Ki of 10.5±1.1 nM.
- GC14149 WAY 208466 dihydrochloride 5-HT6 agonist
-
GC12300
WAY 629 hydrochloride
5-HT2C agonist
- GC15754 WAY-100635 Maleate 5-HT1A receptor agonist
- GC45157 WAY-161503 WAY-161503 is a potent, selective, highly affinity 5-HT2C receptor agonist with a Ki of 4 nM and an EC50 of 12 nM.
- GC31041 Wf-516 Wf-516 is an inhibitor of 5-HT reuptake, and an antagonist of 5-HT1A and 5-HT2A receptors, with Ki of 5 nM and 40 nM for 5-HT1A receptor and 5-HT2A receptor in humans, respectively, and has potent antidepressant activity.
- GC19389 YL0919 YL0919 (YL0919) is an orally active antidepressant agent with dual activity as a highly seletive 5-HT uptake blocker and an effective 5-HT1Areceptor agonist (Ki=0.19 nM).
- GC31503 YM348 YM348 is a potent and orally active 5-HT2C receptor agonist, which shows a high affinity for cloned human 5-HT2C receptor (Ki: 0.89 nM).
- GC17343 Zacopride hydrochloride 5-HT3 receptor antagonist and 5-HT4 receptor agonist
- GC31203 Zatosetron maleate (LY 277359 maleate) Zatosetron maleate (LY 277359 maleate) is a potent and selective 5HT3 receptor antagonist.
- GC37969 Ziprasidone D8 Ziprasidone D8 is deuterium labeled Ziprasidone, which is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity.
- GC11521 Ziprasidone HCl Ziprasidone (CP-88059) hydrochloride is an orally active combined 5-HT and dopamine receptor antagonist.
- GC17808 Zolmitriptan Potent 5-HT1B/1D/1F agonist
- GC14088 Zotepine 5-HT2A receptor and dopamine D2 receptor antagonist